Dimensional Fund Advisors LP lessened its holdings in shares of Molina Healthcare, Inc (NYSE:MOH - Free Report) by 0.7% during the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 683,610 shares of the company's stock after selling 4,635 shares during the period. Dimensional Fund Advisors LP owned 1.26% of Molina Healthcare worth $225,154,000 as of its most recent SEC filing.
Several other institutional investors also recently modified their holdings of MOH. Amalgamated Bank boosted its holdings in shares of Molina Healthcare by 0.3% during the 1st quarter. Amalgamated Bank now owns 11,580 shares of the company's stock valued at $3,814,000 after acquiring an additional 33 shares during the last quarter. Deseret Mutual Benefit Administrators grew its position in Molina Healthcare by 60.7% in the 1st quarter. Deseret Mutual Benefit Administrators now owns 90 shares of the company's stock worth $30,000 after purchasing an additional 34 shares during the period. JLB & Associates Inc. raised its stake in Molina Healthcare by 0.3% during the 1st quarter. JLB & Associates Inc. now owns 10,626 shares of the company's stock valued at $3,500,000 after buying an additional 36 shares during the last quarter. Coldstream Capital Management Inc. lifted its holdings in shares of Molina Healthcare by 2.1% during the 4th quarter. Coldstream Capital Management Inc. now owns 2,346 shares of the company's stock valued at $683,000 after buying an additional 48 shares during the period. Finally, Rothschild Investment LLC boosted its stake in shares of Molina Healthcare by 126.3% in the 1st quarter. Rothschild Investment LLC now owns 86 shares of the company's stock worth $28,000 after buying an additional 48 shares during the last quarter. 98.50% of the stock is currently owned by institutional investors.
Analyst Upgrades and Downgrades
A number of equities research analysts have issued reports on the company. Truist Financial restated a "hold" rating and set a $180.00 price target (down from $335.00) on shares of Molina Healthcare in a research note on Friday, July 25th. UBS Group reduced their target price on shares of Molina Healthcare from $260.00 to $180.00 and set a "neutral" rating for the company in a report on Friday, July 25th. Barclays dropped their price target on shares of Molina Healthcare from $270.00 to $186.00 and set an "equal weight" rating on the stock in a research note on Friday, July 25th. Wells Fargo & Company cut their price objective on shares of Molina Healthcare from $216.00 to $198.00 and set an "overweight" rating for the company in a research report on Friday, August 15th. Finally, Robert W. Baird decreased their target price on Molina Healthcare from $373.00 to $179.00 and set a "neutral" rating on the stock in a report on Friday, July 25th. Three analysts have rated the stock with a Buy rating and ten have assigned a Hold rating to the company's stock. Based on data from MarketBeat.com, the company currently has an average rating of "Hold" and an average price target of $242.91.
Get Our Latest Analysis on MOH
Insider Buying and Selling
In other Molina Healthcare news, Director Ronna Romney sold 700 shares of the company's stock in a transaction that occurred on Wednesday, August 6th. The stock was sold at an average price of $153.74, for a total value of $107,618.00. Following the completion of the transaction, the director directly owned 17,131 shares in the company, valued at $2,633,719.94. This represents a 3.93% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Also, COO James Woys acquired 10,000 shares of the business's stock in a transaction on Monday, August 4th. The shares were bought at an average cost of $155.94 per share, with a total value of $1,559,400.00. Following the completion of the acquisition, the chief operating officer owned 74,331 shares in the company, valued at approximately $11,591,176.14. This represents a 15.54% increase in their ownership of the stock. The disclosure for this purchase can be found here. 1.10% of the stock is currently owned by insiders.
Molina Healthcare Price Performance
Shares of MOH traded up $2.3210 during trading hours on Friday, reaching $175.1510. 619,351 shares of the stock traded hands, compared to its average volume of 990,491. The company has a current ratio of 1.66, a quick ratio of 1.66 and a debt-to-equity ratio of 0.77. Molina Healthcare, Inc has a 52-week low of $151.95 and a 52-week high of $365.23. The company's 50-day moving average price is $213.50 and its two-hundred day moving average price is $278.05. The company has a market cap of $9.49 billion, a P/E ratio of 8.63 and a beta of 0.52.
Molina Healthcare (NYSE:MOH - Get Free Report) last posted its quarterly earnings results on Wednesday, July 23rd. The company reported $5.48 EPS for the quarter, missing analysts' consensus estimates of $5.50 by ($0.02). The business had revenue of $11.43 billion for the quarter, compared to the consensus estimate of $10.94 billion. Molina Healthcare had a net margin of 2.60% and a return on equity of 27.72%. Molina Healthcare's revenue was up 15.7% compared to the same quarter last year. During the same period in the prior year, the business earned $5.86 earnings per share. On average, analysts anticipate that Molina Healthcare, Inc will post 24.4 earnings per share for the current year.
Molina Healthcare Profile
(
Free Report)
Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.
Recommended Stories

Before you consider Molina Healthcare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Molina Healthcare wasn't on the list.
While Molina Healthcare currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.